The Biotech Growth Trust PLC - Appointment of New Director
04 September 2024 - 9:35PM
UK Regulatory
The Biotech Growth Trust PLC -
Appointment of New Director
PR Newswire
LONDON, United Kingdom, September 04
4 September 2024
THE
BIOTECH GROWTH TRUST PLC
(the
"Company")
Appointment of New Director
The Board
of The Biotech Growth Trust PLC is pleased to announce the
appointment of Julie Tankard as an
independent non-executive director of the Company, with effect from
3 September 2024.
Mrs
Tankard has been appointed as the Audit Committee Chair-elect and
is expected to succeed the current Audit Committee Chair,
Julia Le Blan, after Mrs
Le Blan retires at the Company's
next annual general meeting in July
2025.
Mrs
Tankard is a non-executive director and chair of the audit
committee of F&C Investment Trust PLC.
She has 30
years of varied finance experience and is a Fellow of the Chartered
Institute of Management Accountants.
She is a
director of Fincom Advisory Limited providing commercial advice to
businesses, having previously been the Chief Financial Officer and
a Board member of the Port of London where, as well as finance, she was
responsible for risk, procurement, legal and information
technology. She was also a trustee of a defined benefit pension
scheme for six years, working with investment advisors, the scheme
actuary and pensions advisory committee. She sits on the Industrial
Development Advisory Board and previously chaired the audit
committee of Leeds & York NHS Foundation Trust, prior to which
she held various senior positions at BT plc.
The Chair
of The Biotech Growth Trust PLC, Roger
Yates, commented:
"We are
delighted to welcome Julie Tankard
to our Board.
With her
extensive and varied experience in finance, she will bring valuable
insights to the Board and the Audit Committee, where her leadership
will be instrumental in guiding our financial oversight and
governance."
Mrs
Tankard has also been appointed to the Company's Audit Committee,
Management Engagement Committee, Nominations Committee and
Valuation Committee with effect from 3
September 2024.
Her
appointment will be proposed to shareholders for election at the
Annual General Meeting of the Company to be held in July 2025.
There is
no further information to be disclosed under Listing Rule
9.6.13R(2) to (6).
Frostrow
Capital LLP
Company
Secretary
020 3709
8734
Biotech Growth (LSE:BIOG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Biotech Growth (LSE:BIOG)
Historical Stock Chart
From Oct 2023 to Oct 2024